Literature DB >> 1464256

Inhibition of experimental seizures in canines by repetitive vagal stimulation.

J Zabara1.   

Abstract

Repetitive electrical stimulation of the canine cervical vagus nerve interrupts or abolishes motor seizures induced by strychnine and tremors induced by pentylenetetrazol (PTZ). Tremors were defined as rhythmic alternating contractions of opposing muscle groups, exerting much less force than seizure contractions. Seizures were induced by injection boluses of strychnine or PTZ at 1- to 4-min intervals until sustained muscle activity was observed electromyographically (EMG). Vagal stimulation terminated seizures in 0.5-5 s. There were prolonged periods with no spontaneous EMG activity after stimulation. The period of protection was approximately four times the stimulation period. The antiseizure actions of vagal stimulation were not altered by transection of the vagus distal to the stimulating electrode. Optimal stimulus parameters were estimated: strength, approximately 20 V (electrode resistance 1-5 omega); frequency 20-30 Hz; duration, approximately 0.2 ms. These data suggest that the antiseizure effects derive from stimulation of small-diameter afferent unmyelinated fibers in the vagus nerve. These results may form the basis of a new therapeutic approach to epilepsy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464256     DOI: 10.1111/j.1528-1157.1992.tb01751.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  49 in total

1.  Early seizure detection in rats based on vagus nerve activity.

Authors:  Kristian R Harreby; Cristian Sevcencu; Johannes J Struijk
Journal:  Med Biol Eng Comput       Date:  2010-10-02       Impact factor: 2.602

2.  Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat.

Authors:  Rodney W Roosevelt; Douglas C Smith; Richard W Clough; Robert A Jensen; Ronald A Browning
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

Review 3.  Anatomo-Physiologic Basis for Auricular Stimulation.

Authors:  Beniamina Mercante; Francesca Ginatempo; Andrea Manca; Francesco Melis; Paolo Enrico; Franca Deriu
Journal:  Med Acupunct       Date:  2018-06-01

Review 4.  Vagus Nerve Stimulation for the Treatment of Epilepsy.

Authors:  Hernán F J González; Aaron Yengo-Kahn; Dario J Englot
Journal:  Neurosurg Clin N Am       Date:  2019-04       Impact factor: 2.509

Review 5.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

6.  Meta-analysis of vagus nerve stimulation treatment for epilepsy: correlation between device setting parameters and acute response.

Authors:  S Ghani; J Vilensky; B Turner; R S Tubbs; M Loukas
Journal:  Childs Nerv Syst       Date:  2015-10-22       Impact factor: 1.475

7.  [Treatment of epilepsy: peripheral and central stimulation techniques].

Authors:  A Schulze-Bonhage; V Coenen
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 8.  Vagus nerve stimulation for epilepsy and depression.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 9.  Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS).

Authors:  Mark S George; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.

Authors:  Pablo Andrade; Lieke H M Noblesse; Yasin Temel; Linda Ackermans; Lee W Lim; Harry W M Steinbusch; Veerle Visser-Vandewalle
Journal:  Acta Neurochir (Wien)       Date:  2010-01-26       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.